PH1 OF A KIND

Serial Number 88489381
Registration 6471552
700

Registration Progress

Application Filed
Jun 26, 2019
Under Examination
Dec 10, 2019
Approved for Publication
Oct 15, 2019
Published for Opposition
Oct 15, 2019
Registered
Aug 31, 2021

Trademark Image

PH1 OF A KIND

Basic Information

Serial Number
88489381
Registration Number
6471552
Filing Date
June 26, 2019
Registration Date
August 31, 2021
Published for Opposition
October 15, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 31, 2021
Registration
Registered
Classes
035

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street, 3rd Floor
CAMBRIDGE, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
CAMBRIDGE, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
CAMBRIDGE, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
CAMBRIDGE, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
758 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-31)
Due Date
August 31, 2027
Grace Period Ends
February 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Mar 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 31, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 27, 2021 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN Loading...
Jul 27, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 27, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 27, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 19, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 19, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2021 IUAF S USE AMENDMENT FILED Loading...
Jun 9, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 7, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 7, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 4, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 4, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 4, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 9, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 10, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 10, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 10, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 6, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 29, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness about primary hyperoxaluria among affected individuals and their families
First Use Anywhere: Jun 21, 2019
First Use in Commerce: Jun 21, 2019

Additional Information

Pseudo Mark
PRIMARY HYPEROXALURIA ONE OF A KIND

Classification

International Classes
035